Ivabradine
Back to searchMolecule Structure
Scientific Name
Ivabradine
Description of the Drug
Ivabradine is a HCN channel blocker used to reduce the risk of hospitalization for worsening heart failure in adult patients and for treatment of stable symptomatic heart failure as a result of dilated cardiomyopathy in pediatric patients.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09083
http://www.drugbank.ca/drugs/DB09083
Brand Name(s)
Corlanor, Procoralan
Company Owner(s)
Amgen Inc, Centaur Pharmaceuticals Pvt Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | SINGLE PROTEIN | BLOCKER | CHEMBL1250417 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL23472 | ||
PharmGKB | PA166123415 | ||
DrugBank | DB09083 | ||
PubChem: Thomson Pharma | 14858507 | 14809487 | |
PubChem | 132999 | ||
Nikkaji | J582.018I | ||
BindingDB | 50326992 | ||
EPA CompTox Dashboard | DTXSID2048240 | ||
DrugCentral | 3312 | ||
ChemicalBook | CB41178988 | ||
Guide to Pharmacology | 2357 | ||
rxnorm | CORLANOR | IVABRADINE HYDROCHLORIDE | IVABRADINE |
ChEBI | 85966 | ||
ZINC | ZINC000003805768 |